Navigation Links
Precision Antibody Expands Antibody Characterization Services
Date:3/15/2012

COLUMBIA, Md., March 15, 2012 /PRNewswire-iReach/ -- Precision Antibody, a market leader in contract antibody services, announced today that they have expanded their antibody characterization services to include Fortebio's  Octet RED96™ system, a multi-functional, label-free, real-time binding analysis instrument.  

Since 2006, Precision Antibody has been providing antibody characterization services using Biacore™ 3000 by GE Healthcare, a Surface Plasmon Resonance (SPR) based real time binding kinetic analysis machine.  We are now proud to announce the addition of the Octet RED96 from ForteBio to enhance our cutting edge antibody characterization capabilities and services. The Octet Red96 uses Bio-Layer Interferometry (BLI) technology for the detection of label-free real time molecular interaction analysis.

The Octet Red96 can perform up to 8 label-free binding assays at one time, allowing high throughput antibody screening and characterization.   The technology is fully integrated into Precision Antibody's custom monoclonal antibody development platform to aid the selection of suitable application-specific clones otherwise missed in a conventional EIA based screening format.

Octet Red96 can be used for the screening of monoclonal antibodies using unlabeled free antigen in solution, antibody quantification, affinity based antibody ranking, epitope binning, full binding kinetic analysis, and more.  Binding kinetic analyses can be performed with molecules as small as 150 Dalton.

"We are excited to offer an additional cutting edge technology to our customers. Together with our state-of-the-art monoclonal antibody development platform technology, we continue to deliver the highest quality antibodies to our customers" says Jun Hayashi, Ph.D., the VP of Precision Antibody.

About Precision Antibody (www.precisionantibody.com)

Precision Antibody™ provides customized, high-affinity monoclonal and polyclonal antibodies to pharmaceutical and biotechnology companies as well as to academic, government, and nonprofit research institutions.  Precision Antibody™ develops antibodies for the use in research and discovery, for the development of preclinical therapeutic and diagnostic targets, and for QC and PK studies. The company's products and services are based on a proprietary antibody discovery and development platform technology that enables rapid development of target-specific, high-affinity antibodies. Precision Antibody™ provides one-stop service for antibody development, characterization (isotype and affinity determination), purification/production (from pilot to large scale), and conjugation, as well as stable cell line development and hybridoma cell banking. Precision Antibody™ is a wholly owned service division of A&G Pharmaceutical, Inc. (www.agpharma.com ) and is based in Columbia, MD.

About Octet RED96™ & Biacore™

Octet RED96™ is a registered trademark of ForteBio, Inc.  Precision Antibody is not affiliated with ForteBio, Inc. products or services.  Biacore™ is a registered trademark of GE Healthcare. Precision Antibody is not affiliated with GE Healthcare products or services.

Media Contact: Michael Keefe, Precision Antibody, 410-884-4100, mkeefe@precisionantibody.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Precision Antibody
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
2. Cogmedix Provides High-Precision Subassembly for LensAR Revolutionary Refractive Laser
3. Boston Scientific Receives FDA Approval for New Infinion™ 16 Percutaneous Lead for Precision Plus™ Spinal Cord Stimulator System
4. TIs new MSP430™ microcontrollers enable more performance and higher precision in home automation, industrial and portable medical applications
5. Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcanos Precision Guided Therapy Technologies
6. TechPrecision Corporations WCMC Division Adds Second Sapphire Customer
7. Vapotherm® Announces FDA Clearance for Precision Flow® Heliox System
8. FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays
9. Precision Therapeutics Named on Inc. 500
10. 5000 2011 List and Recognized for Achievements in Personalized Medicine Industry
11. Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... MOUNTAIN VIEW, Calif. , Feb. 10, ... result of a synergistic confluence of various ... unique value propositions, previously unavailable. These opportunities ... convergence and convergence, in turn, drives the ... Today,s entrepreneurial scenario is characterized by technology ...
(Date:2/10/2016)... Jersey and OR AKIVA, Israel ... Regentis Biomaterials Ltd., a leader in the ... Series D investment round on February 5, 2016. The ... Group ("Haisco"), a leading Chinese pharmaceutical manufacturer, and ... SCP Vitalife Partners, Generali Financial Holdings and both the ...
(Date:2/10/2016)... ALSP, Inc. announced that it has appointed Col.(Retired) Dallas ... preparation for its move into clinical trials with its lead ... are pleased to welcome Dallas Hack onto the ... of such practical knowledge and far-reaching experience in Traumatic Brain ... broad experience and success as a clinician and researcher in ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand Interpreting , ... recently partnered with Heart City Health Center to improve access to ... Heart City Health Center has provided the Elkhart community with access to high ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize critical ... leave patients with dental emergencies at risk of losing a tooth or their smiles. ... , Common dental emergencies include:, , Avulsed or knocked-out ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Ongoing news of ... Life Care Association™ (ALCA) to conduct a survey that takes a closer look at ... today illustrates the prevalence and causes of TBI among the aging population, and identifies ...
(Date:2/10/2016)... , ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: ... report results for the fourth quarter and full year ended December 31, 2015 on ... conference call and webcast for the investment community following the release at 4:30 PM ...
(Date:2/10/2016)... ... 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves ... The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp explains ... is March 16, 2016. A free review copy is available to the media ...
Breaking Medicine News(10 mins):